Search results for " hyaluronic acid"

showing 10 items of 61 documents

Imatinib-Loaded Micelles of Hyaluronic Acid Derivatives for Potential Treatment of Neovascular Ocular Diseases

2018

In this work, new micellar systems able to cross corneal barrier and to improve the permeation of imatinib free base were prepared and characterized. HA-EDA-C-16, HA-EDA-C-16-PEG, and HA-EDA-C-16-CRN micelles were synthesized starting from hyaluronic acid (HA), ethylenediamine (EDA), hexadecyl chains (C-16), polyethylene glycol (PEG), or L-carnitine (CRN). These nanocarriers showed optimal particle size and mucoadhesive properties. Imatinib-loaded micelles were able to interact with corneal barrier and to promote imatinib transcorneal permeation and penetration. In addition, a study was conducted to understand the in vitro imatinib inhibitory effect on a choroidal neovascularization process…

0301 basic medicineCell SurvivalDrug CompoundingPharmaceutical ScienceAdministration Ophthalmic02 engineering and technologyPolyethylene glycolMicellePermeabilityCell LinePolyethylene GlycolsCornea03 medical and health scienceschemistry.chemical_compoundocular drug delivery hyaluronic acid polymeric micelles imatinib transcorneal permeation ocular neovascular diseasesCarnitinehemic and lymphatic diseasesDrug DiscoveryHyaluronic acidPEG ratiomedicineocular drug delivery; hyaluronic acid; polymeric micelles; imatinib; transcorneal permeation; ocular neovascular diseasesAnimalsHumansHyaluronic AcidParticle SizeProtein Kinase InhibitorsneoplasmsMicellesDrug CarriersEndothelial CellsImatinibPermeation021001 nanoscience & nanotechnologyEthylenediaminesIn vitroChoroidal NeovascularizationDrug Liberation030104 developmental biologychemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoBiophysicsImatinib MesylateMolecular Medicinelipids (amino acids peptides and proteins)CattleNanocarriers0210 nano-technologymedicine.drug
researchProduct

Protective and regenerative effects of a novel medical device against esophageal mucosal damage using in vitro and ex vivo models.

2020

Gastroesophageal reflux disease (GERD) is a common digestive disorder that causes esophagitis and injuries to the esophageal mucosa. GERD symptoms are recurrent during pregnancy and their treatment is focused on lifestyle changes and nonprescription medicines. The aim of this study was to characterize the mechanism of action of a new patented medical device, an oral formulation containing hyaluronic acid, rice extract, and amino acids dispersed in a bioadhesive polymer matrix, by assessing its protective effects in in vitro and ex vivo models of esophageal mucosa damage. Acidic bile salts and pepsin cocktail (BSC) added to CP-A and COLO-680 N esophagus cells were used as an in vitro GERD mo…

0301 basic medicineEsophageal MucosaHyaluronic acidRM1-950PharmacologyPermeability03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePepsinCell Line TumorDigestive disorderHyaluronic acidMedicineHumansRegenerationEsophagusAmino AcidsHyaluronic AcidEvans BlueMedical devicePharmacologybiologybusiness.industryBioadhesive polymer; Gastroesophageal reflux disease (GERD); Hyaluronic acid; Medical device; Rice extractPlant ExtractsRice extractAdhesivenessOryzaGeneral MedicineBioadhesive polymermedicine.diseaseGastroesophageal reflux disease (GERD)digestive system diseases030104 developmental biologymedicine.anatomical_structurechemistryEquipment and Supplies030220 oncology & carcinogenesisbiology.proteinGERDGastroesophageal RefluxTherapeutics. PharmacologybusinessWound healingEx vivoBiomedicinepharmacotherapy = Biomedecinepharmacotherapie
researchProduct

Hyaluronic-based antibacterial hydrogel coating for implantable biomaterials in orthopedics and trauma. From basic research to clinical applications.

2018

Bacterial colonization of implanted biomaterials remains one of the most challenging complications in orthopedics and trauma surgery, with extremely high social and economic costs. Antibacterial coating of implants has been advocated by many experts as a possible solution to reduce the burden of implant-related infection and several different solutions have been proposed in the last decades. However, while most of the investigated technologies have shown their efficacy in vitro and/or in vivo, only few were able to reach the market, due to clinical, industrial, economic and regulatory issues. Hyaluronic acid composites have been previously shown to possess antifouling capabilities and have …

030222 orthopedics03 medical and health sciences0302 clinical medicineHydrogel coatingcoating hydrogel hyaluronic acid DAC infection implant orthopedic trauma prosthesis preventionbusiness.industryBasic researchMedicine030212 general & internal medicinebusinessGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)Biomedical engineering
researchProduct

Increased intrahepatic and circulating levels of endoglin, a TGF-β1 co-receptor, in patients with chronic hepatitis C virus infection: relationship t…

2006

Endoglin, a transforming growth factor (TGF)-beta1 co-receptor, has been associated with renal and cutaneous fibrosis, as overexpression of this protein has been observed in biopsies from patients with glomerulosclerosis and scleroderma, respectively. Our aim was to evaluate whether endoglin may be associated with hepatic fibrosis featuring chronic hepatitis C virus (HCV) infection. Fifty-two anti-HCV+ patients, five anti-HCV- patients and 27 healthy subjects were studied. Western blot and immunohistochemistry were used to quantify the expression levels of endoglin and TGF-beta1 in liver biopsy samples, and serum concentrations of endoglin and hyaluronic acid were determined by enzyme-linke…

AdultLiver CirrhosisMalePathologymedicine.medical_specialtyHepatitis C virusBlotting WesternEnzyme-Linked Immunosorbent AssayReceptors Cell SurfaceSerum Hyaluronic Acidmedicine.disease_causeAntigens CDFibrosishemic and lymphatic diseasesVirologyotorhinolaryngologic diseasesmedicineHumansHyaluronic AcidHepatologymedicine.diagnostic_testbusiness.industryEndoglinHepatitis CHepatitis C ChronicMiddle AgedEndoglinmedicine.diseaseFibrosisImmunohistochemistryInfectious DiseasesLiverLiver biopsyHepatic stellate cellFemaleHepatic fibrosisbusinessBiomarkersJournal of Viral Hepatitis
researchProduct

Broncalt®, class II medical device, in patients with acute upper airways disease: a survey in clinical practice.

2019

Inflammation is a common pathogenic mechanism involved in many otorhinolaryngological (ORL) disorders. Broncalt® is a class II Medical Device containing: thermal water (Medesano, PR, Italy), hyaluronic acid, and grapefruit seed extract. It has been reported that it exerted a safe and effective anti-inflammatory, washing, and antimicrobial activity by virtue of these components. Therefore, the aim of the current survey, conducted in clinical practice of 84 Italian ORL centers, was to evaluate its safety and efficacy in the treatment of patients with acute upper airways disease. The 3,533 (1,797 males, mean age 43.5 years) patients were evaluated at baseline (T0) and after a 2-week treatment …

AdultMaleupper airwaysAdolescentPlant ExtractsAcute disease; Grapefruit seed extract; Hyaluronic acid; Thermal water; Upper airwaysgrapefruit seed extractthermal waterWaterupper airways acute disease thermal water hyaluronic acid grapefruit seed extractNOOtolaryngologyOtorhinolaryngologic DiseasesYoung AdultTreatment OutcomeEquipment and SuppliesHealth Care SurveysAcute DiseaseSeedshyaluronic acidHumansFemaleOriginal ArticleCitrus paradisiActa bio-medica : Atenei Parmensis
researchProduct

Is intravesical instillation of hyaluronic acid and chondroitin sulfate useful in preventing recurrent bacterial cystitis? A multicenter case control…

2015

Abstract Objective Urinary tract infections (UTIs) are common in the female population and, over a lifetime, about half of women have at least one episode of UTI requiring antibiotic therapy. The aim of the current study was to compare two different strategies for preventing recurrent bacterial cystitis: intravesical instillation of hyaluronic acid (HA) plus chondroitin sulfate (CS), and antibiotic prophylaxis with sulfamethoxazole plus trimethoprim. Materials and methods This was a retrospective review of two different cohorts of women affected by recurrent bacterial cystitis. Cases (experimental group) were women who received intravesical instillations of a sterile solution of high concen…

Adultmedicine.medical_specialtyRecurrent bacterial cystitismedicine.drug_classUrinary systemCystitiAntibioticsUrinalysislcsh:Gynecology and obstetricsGastroenterologyantibioticsantibiotics; chondroitin sulfate; cystitis; hyaluronic acidchemistry.chemical_compoundAdjuvants ImmunologicRecurrenceInternal medicineObstetrics and GynaecologyHyaluronic acidCystitismedicineHumansChondroitin sulfateAntibiotic prophylaxisHyaluronic Acidlcsh:RG1-991antibiotics chondroitin sulfate cystitis hyaluronic acidchondroitin sulfateRetrospective StudiesDose-Response Relationship Drugbusiness.industrySulfamethoxazoleChondroitin SulfatesAntibioticObstetrics and GynecologySettore MED/40 - Ginecologia E OstetriciaTrimethoprimSurgeryAdministration IntravesicalInstillation DrugchemistryUrinary Tract InfectionsDrug Therapy CombinationFemalebusinessmedicine.drugFollow-Up StudiesTaiwanese journal of obstetricsgynecology
researchProduct

Efficacy and safety study of an eyelid gel after repeated nocturnal application in healthy contact lens users and non-users

2020

Purpose: To evaluate skin biocompatibility of a nighttime hydrating eyelid gel and possible ocular surface effects in contact lens users (CLU) and non-contact lens users (NCLU). The formulation is registered as a medical device as Tridocosahexaenoine-AOX® (TDHA-AOX) (a concentrated DHA triglyceride), containing also hyaluronic acid (HA). Methods: A prospective, randomized, masked clinical trial was performed with 62 participants of both sexes, aged 20–70 years, split into: (1) CLU (n = 30) and (2) NCLU (n = 32). All participants were instructed to apply a single dose of the moisturizing gel (containing TDHA-AOX and HA) nightly to the upper and inner eyelids of their right eye (RE) only, and…

DHA docosahexaenoic acidNon usersFBUT fluorescein break-up timeALA alpha linolenic acidTDAH-AOX tridocosahexaenoin-antioxidantNCLU non contact lens users0302 clinical medicineLC PUFAs long chain polyunsaturated fatty acidsMedicineCL contact lensesOS ocular surfaceHA hyaluronic acidOSDI ocular surface disease indexDE dry eyeCLU contact lens usersCLDEQ contact lens dry eye questionnaireVEGF vascular endothelial growth factorDocosahexaenoic acidBMC biomicroscopymedicine.anatomical_structureMedicamentosCytokinesOftalmologíaOriginal ArticleBCVA best corrected visual acuitymedicine.medical_specialtyOcular surface dysfunctionCorneal stainingContact LensesHyaluronic acidRE right eyeDEs dry eye syndrome03 medical and health sciencesOphthalmologyHumansAdverse effectbusiness.industryEyelidsEPA eicosapentaenoic acidAnatomía ocularIOP intraocular pressureeye diseasesClinical trialContact lensMOISTURIZING GEL030221 ophthalmology & optometryTearsLE left eyeEyelidsense organsbusiness030217 neurology & neurosurgeryOptometry
researchProduct

Hyaluronic acid and its derivatives in drug delivery and imaging: Recent advances and challenges.

2015

Hyaluronic acid (HA) is a biodegradable, biocompatible, nontoxic, and non-immunogenic glycosaminoglycan used for various biomedical applications. The interaction of HA with the CD44 receptor, whose expression is elevated on the surface of many types of tumor cells, makes this polymer a promising candidate for intracellular delivery of imaging and anticancer agents exploiting a receptor-mediated active targeting strategy. Therefore, HA and its derivatives have been most investigated for the development of several carrier systems intended for cancer diagnosis and therapy. Nonetheless, different and important delivery applications of the polysaccharide have also been described, including gene …

Diagnostic ImagingCarbon nanotubes; Drug delivery; Hyaluronic acid; Intracellular delivery; Quantum dots; TheranosticsPolyestersCarbon nanotubesAcrylic ResinsPharmaceutical ScienceTumor cellsNanotechnologyPolyethylene Glycolschemistry.chemical_compoundDrug Delivery SystemsPolylactic Acid-Polyglycolic Acid CopolymerHyaluronic acidMedicineHumansLactic AcidHyaluronic Acidbusiness.industryQuantum dotsNanotubes CarbonHydrogelsGeneral MedicineIntracellular deliveryBiocompatible materialTheranosticschemistryDrug deliveryDrug deliveryNanocarriersbusinessPolyglycolic AcidBiotechnologyEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V
researchProduct

Design and development of hyaluronan-functionalized polybenzofulvene nanoparticles as CD44 receptor mediated drug delivery system

2017

A tri-component polymer brush (TCPB), composed of a polybenzofulvene copolymer bearing low molecular weight hyaluronic acid (HA) on the surface of its cylindrical brush-like backbone and oligo-PEG fractions, was employed in the preparation of 350 nm nanostructured drug delivery systems capable of delivering the anticancer drug doxorubicin. The obtained drug delivery systems were characterized on the basis of drug loading and release, dimensions and zeta potential, morphology and in vitro cell activity, and uptake on three different human cell lines, namely the bronchial epithelial 16HBE, the breast adenocarcinoma MCF-7, and the colon cancer HCT116 cells. Finally, the ability of doxorubicin…

DrugMaterials scienceAtomic and Molecular Physics and Opticmedia_common.quotation_subjectHyaluronic acidCD44 receptorBioengineering02 engineering and technologyPharmacology010402 general chemistry01 natural sciencesCD44 receptor; Doxorubicin; Hyaluronic acid; Nanomedicine; Polybenzofulvene; Tri-component polymer brush TCPB; Bioengineering; Chemistry (all); Atomic and Molecular Physics and Optics; Modeling and Simulation; Materials Science (all); Condensed Matter Physicschemistry.chemical_compoundAtomic and Molecular PhysicsHyaluronic acidTri-component polymer brush TCPBmedicineGeneral Materials ScienceDoxorubicinmedia_commonbiologyCD44Chemistry (all)General Chemistry021001 nanoscience & nanotechnologyCondensed Matter PhysicsAtomic and Molecular Physics and Optics0104 chemical sciencesNanomedicinechemistryTargeted drug deliveryDoxorubicinModeling and SimulationDrug deliveryCancer cellbiology.proteinBiophysicsNanomedicineMaterials Science (all)Polybenzofulveneand Optics0210 nano-technologymedicine.drug
researchProduct

Injectable in situ forming microgels of hyaluronic acid-g-polylactic acid for methylprednisolone release

2013

Abstract A hydrophobic derivative of hyaluronic acid (HA), obtained by grafting polylactic acid (PLA) to the polysaccharide, has been exploited to produce injectable in situ forming microgels. First of all, self assembling properties of HA-g-PLA copolymer have been evaluated by determining the critical aggregation concentration (CAC) value, then this copolymer has been dissolved in a mixture water/NMP 5:2 v/v with a concentration greater than CAC. When solutions at 1% or 2% w/v were injected into Dulbecco phosphate buffer solution (DPBS) pH 7.4, microgels promptly are formed. Their stability in DPBS pH 7.4 in the absence or in the presence of hyaluronidase and cell compatibility have been e…

Drugchemistry.chemical_classificationMaterials sciencePolymers and Plasticsmedia_common.quotation_subjectOrganic ChemistryGeneral Physics and Astronomymicrogels hyaluronic acid methylprednisolone drug delivery systemGraftingPolysaccharidechemistry.chemical_compoundPolylactic acidchemistryMethylprednisoloneHyaluronidaseSettore CHIM/09 - Farmaceutico Tecnologico ApplicativoPolymer chemistryHyaluronic acidMaterials ChemistrymedicineCopolymermedicine.drugmedia_commonNuclear chemistry
researchProduct